TMCnet News
Research and Markets: Coagulation Self-Testing Market to 2020Research and Markets (http://www.researchandmarkets.com/research/fhdmp3/coagulation) has announced the addition of the "Coagulation Self-testing to 2020" report to their offering. The size and future potential of the coagulation self-testing market has been evolving over the past 24 months as two competing forces work to inject uncertainty into future demand. Demographic and incidence data indicate a definite upward trend in the clinical and managed care demand for anticoagulation therapeutics. But the commercialization of novel oral anticoagulants (NOACs) - a new class of drugs that does not require routine coagulation monitoring - will work to reduce demand for coagulation self-testing. The result will be a muddled global market where demand among countries and regions will vary based on individual market factors. To minimize risk and fully engage addressable markets, participants must commit to a comprehensive understanding of the key markets in which they currently, or plan to, compete. What You Will Learn - What are the marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy? - What is the status and prospects of coagulation self-test devices currently in development? - What is the market potential and commercialization risks and opporunities for coagulation self-test devices? - What are the key patient self-test device design issues and evolving market factors for coagulation self-testing? - What is the impact of coagulation self-test technology and devices on coagulation management markets? - What is the role and impact of third-party PT/INR self-test services on device demand and patient acceptance? - Who are the market participants in the coagulation self-test segment, and what are their technology and market strategies? - Who are the market leaders; what is the size of the market today, and what will it be in 2020? - What is the impact of novel oral anticoagulants on the future commercial growth of coagulation self-test devices? Key Topics Covered: 1. Executive Summary 2. Anticoagulation Therapy Market Dynamics - Anticoagulation Healthcare Economics - Oral Anticoagulation Therapy - Monitoring Prothrombin Time - Competing Coagulation Tests - Key Factors in Patient Compliance - Market Drivers - Industry Alignment and Competitive Landscape 3. Coagulation Self-Testing Device Design Factors - Standardization of PT/INR Testing - Accuracy and Precision - Sampling Method - Endpoint Detection - Patient/User Interface - Wireless Technology 4. Commercialization Factors - Managed Care and Reimbursement - Third-party Patient Training & Support - Proprietary Technology 5. Market Factors - Indications and Market Segments - Novel Oral Anticoagulants - Patient Demographics - Regulations and Standards - Patient/Consumer Sentiment 6. Patient Self-Testing Product Assessments - Commercial Products - CoaguChek - CoaguSense - InRatio - i-STAT 7. Development-Stage Devices - iLine Microsystems - Microvisk - Universal Biosensors - FlexLife Health 8. Market Analysis, Data and Forecasts - North America - Western Europe - Eastern Europe - Asia - MENA - South America 9. Company Profiles For more information visit http://www.researchandmarkets.com/research/fhdmp3/coagulation
View source version on businesswire.com: http://www.businesswire.com/news/home/20150629005499/en/ |